Ashley Cordova Net Worth & Insider Trades
Ashley Cordova - Chief Financial Officer, Novocure Ltd
What is Ashley Cordova's Net Worth?
The current estimated net worth of Novocure Ltd's Chief Financial Officer, Ashley Cordova, is estimated to be about $5.13M . Ashley Cordova owns about 96,062 units of Novocure Ltd common stock. In the last 3 years at Novocure Ltd, Ashley Cordova has sold an estimated value of $4.58M worth.
What is Ashley Cordova's Past Insider Trading?
Ashley Cordova's largest purchase order was 36,624 units , worth over $1.06M on August 16, 2021. Ashley Cordova's largest sale order was 28,357 units , worth over $3.75M on August 16, 2021. In total, Ashley Cordova has made about 20 transactions over 3 years of their time at Novocure Ltd. Ashley Cordova usually trades in March, with the busiest year in 2021 and 2022. The most recent transaction was a sale order of 2,198 units , worth over $167.84K on March 2, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cordova Ashley
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What was Ashley Cordova's Salary in 2020?
As Chief Financial Officer of Novocure Ltd, Ashley Cordova has a total base salary of $367,175 . Ashley Cordova received compensation valued at about $3,243,249 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of a bonus of $300,000 , stock awards of $1,374,846 , option awards of $873,201 , other earnings, plans or compensations of $318,750 , and other compensation of $9,277 .
What is Ashley Cordova's' Mailing Address?
- Mailing address is 20 Valley Stream Parkway, Suite 300 Malvern PA 19355 PA
Novocure Ltd Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
William Doyle | 2020 | $772,500 | $0 | $13,893,701 | $0 | $1,053,000 | $4,500 | $15,723,701 |
William Doyle | 2019 | $750,000 | $0 | $1,654,987 | $4,972,114 | $891,000 | $18,000 | $8,286,101 |
William Doyle | 2018 | $750,000 | $0 | $587,505 | $2,359,400 | $843,750 | $18,000 | $4,558,655 |
Asaf Danziger | 2020 | $781,868 | $0 | $6,946,850 | $0 | $934,607 | $293,379 | $8,956,704 |
Asaf Danziger | 2019 | $702,295 | $0 | $1,155,020 | $4,472,183 | $693,139 | $293,970 | $7,316,607 |
Asaf Danziger | 2018 | $692,675 | $0 | $587,505 | $2,359,400 | $644,266 | $286,448 | $4,570,294 |
Wilhelmus Groenhuysen | 2020 | $611,400 | $250,000 | $3,666,529 | $1,827,243 | $553,500 | $29,252 | $6,937,924 |
Wilhelmus Groenhuysen | 2019 | $600,600 | $0 | $962,485 | $2,202,814 | $396,396 | $33,789 | $4,196,084 |
Wilhelmus Groenhuysen | 2018 | $600,600 | $0 | $489,580 | $1,966,162 | $375,375 | $27,500 | $3,459,217 |
Ashley Cordova | 2020 | $367,175 | $300,000 | $1,374,846 | $873,201 | $318,750 | $9,277 | $3,243,249 |
Pritesh Shah | 2020 | $481,250 | $0 | $3,333,276 | $1,661,147 | $450,000 | $14,925 | $5,940,598 |
Pritesh Shah | 2019 | $425,000 | $0 | $867,982 | $2,027,390 | $280,500 | $73,061 | $3,673,933 |
Pritesh Shah | 2018 | $400,000 | $0 | $768,196 | $1,616,575 | $265,625 | $20,100 | $3,070,496 |
Todd Longsworth | 2020 | $437,500 | $300,000 | $2,666,583 | $1,328,550 | $405,000 | $11,739 | $5,149,372 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1645113/000164511321000059/nvcr-20210609xdef14a.htm
What are Novocure Ltd's Past Insider Trades?
Novocure Ltd's most recent insider trade came on November 8, 2023 by Pritesh Shah who sold 382 units worth $4.83K . In the last 7 years, insiders at Novocure Ltd have sold an estimated value of $590.08M and bought an estimated value of $141.8M worth of shares. Insider trading is most common in March, with the busiest year in 2019. The most active traders at the company are Danziger Asaf, Chief Executive Officer, Groenhuysen Wilhelmus Cm, Chief Operating Officer, and Pritesh Shah, Chief Growth Officer .
NovoCure Ltd Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |